Listed

PepGen Inc.

PEPGNasdaqCIK 1835597HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$18.9m, Q2 FY2026
Net income−$17.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m20.5Research and development, Q3 FY2023, three months to 2023-09-30$20.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure16.3Research and development, Q4 FY2023, three months to 2023-12-31$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-24, accession 0000950170-25-025226. Derived: 12-month figure less the 9-month figure.Report this figure14.7Research and development, Q1 FY2024, three months to 2024-03-31$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure25.1Research and development, Q2 FY2024, three months to 2024-06-30$25.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure17.7Research and development, Q3 FY2024, three months to 2024-09-30$17.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure19.0Research and development, Q4 FY2024, three months to 2024-12-31$19.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure25.4Research and development, Q1 FY2025, three months to 2025-03-31$25.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure18.4Research and development, Q2 FY2025, three months to 2025-06-30$18.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure13.4Research and development, Q3 FY2025, three months to 2025-09-30$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure13.9Research and development, Q4 FY2025, three months to 2025-12-31$13.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure13.0Research and development, Q1 FY2026, three months to 2026-03-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure12.5Research and development, Q2 FY2026, three months to 2026-06-30$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Operating income$m(24.8)Operating income, Q3 FY2023, three months to 2023-09-30−$24.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure(20.8)Operating income, Q4 FY2023, three months to 2023-12-31−$20.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-24, accession 0000950170-25-025226. Derived: 12-month figure less the 9-month figure.Report this figure(19.8)Operating income, Q1 FY2024, three months to 2024-03-31−$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure(30.4)Operating income, Q2 FY2024, three months to 2024-06-30−$30.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure(23.2)Operating income, Q3 FY2024, three months to 2024-09-30−$23.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(24.3)Operating income, Q4 FY2024, three months to 2024-12-31−$24.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure(31.3)Operating income, Q1 FY2025, three months to 2025-03-31−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(23.9)Operating income, Q2 FY2025, three months to 2025-06-30−$23.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure(18.7)Operating income, Q3 FY2025, three months to 2025-09-30−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(19.7)Operating income, Q4 FY2025, three months to 2025-12-31−$19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure(18.9)Operating income, Q1 FY2026, three months to 2026-03-31−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(18.9)Operating income, Q2 FY2026, three months to 2026-06-30−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Income tax$mnot reportednot reportednot reported0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(0.6)Income tax, Q4 FY2024, three months to 2024-12-31−$617.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$48.9k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$16.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Net income$m(23.3)Net income, Q3 FY2023, three months to 2023-09-30−$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure(19.5)Net income, Q4 FY2023, three months to 2023-12-31−$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-24, accession 0000950170-25-025226. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Net income, Q1 FY2024, three months to 2024-03-31−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(28.3)Net income, Q2 FY2024, three months to 2024-06-30−$28.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(21.4)Net income, Q3 FY2024, three months to 2024-09-30−$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(22.2)Net income, Q4 FY2024, three months to 2024-12-31−$22.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure(30.2)Net income, Q1 FY2025, three months to 2025-03-31−$30.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure(23.1)Net income, Q2 FY2025, three months to 2025-06-30−$23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure(18.0)Net income, Q3 FY2025, three months to 2025-09-30−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure(18.3)Net income, Q4 FY2025, three months to 2025-12-31−$18.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure(17.8)Net income, Q1 FY2026, three months to 2026-03-31−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure(17.8)Net income, Q2 FY2026, three months to 2026-06-30−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Diluted EPS$ per share(0.98)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figurenot reported(0.63)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure(0.87)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure(0.66)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figurenot reported(0.92)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(0.70)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure(0.52)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(0.26)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Basic EPS$ per share(0.98)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figurenot reported(0.63)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure(0.87)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure(0.66)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figurenot reported(0.92)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(0.70)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure(0.52)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figurenot reported(0.26)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(0.26)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure

Balance sheet

Cash and equivalents$22.8m, Q2 FY2026
Shareholders' equity$119.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m130Cash and equivalents, Q3 FY2023, at 2023-09-30$129.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure80.8Cash and equivalents, FY2023, at 2023-12-31$80.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-24, accession 0000950170-25-025226.Report this figure134Cash and equivalents, Q1 FY2024, at 2024-03-31$133.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure66.1Cash and equivalents, Q2 FY2024, at 2024-06-30$66.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure42.3Cash and equivalents, Q3 FY2024, at 2024-09-30$42.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure49.4Cash and equivalents, FY2024, at 2024-12-31$49.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-04, accession 0001193125-26-091536.Report this figure43.6Cash and equivalents, Q1 FY2025, at 2025-03-31$43.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure35.1Cash and equivalents, Q2 FY2025, at 2025-06-30$35.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure143Cash and equivalents, Q3 FY2025, at 2025-09-30$142.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure60.5Cash and equivalents, FY2025, at 2025-12-31$60.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure42.2Cash and equivalents, Q1 FY2026, at 2026-03-31$42.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure22.8Cash and equivalents, Q2 FY2026, at 2026-06-30$22.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Current assets$m133Current assets, Q3 FY2023, at 2023-09-30$133.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060702.Report this figure113Current assets, FY2023, at 2023-12-31$112.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-24, accession 0000950170-25-025226.Report this figure178Current assets, Q1 FY2024, at 2024-03-31$177.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059519.Report this figure165Current assets, Q2 FY2024, at 2024-06-30$164.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093351.Report this figure142Current assets, Q3 FY2024, at 2024-09-30$142.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure124Current assets, FY2024, at 2024-12-31$123.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-04, accession 0001193125-26-091536.Report this figure101Current assets, Q1 FY2025, at 2025-03-31$101.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure77.5Current assets, Q2 FY2025, at 2025-06-30$77.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure166Current assets, Q3 FY2025, at 2025-09-30$166.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure151Current assets, FY2025, at 2025-12-31$151.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure134Current assets, Q1 FY2026, at 2026-03-31$134.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure120Current assets, Q2 FY2026, at 2026-06-30$120.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Total assets$m164Total assets, Q3 FY2023, at 2023-09-30$164.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-060702.Report this figure143Total assets, FY2023, at 2023-12-31$143.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-24, accession 0000950170-25-025226.Report this figure207Total assets, Q1 FY2024, at 2024-03-31$207.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059519.Report this figure194Total assets, Q2 FY2024, at 2024-06-30$193.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093351.Report this figure170Total assets, Q3 FY2024, at 2024-09-30$170.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure151Total assets, FY2024, at 2024-12-31$150.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-04, accession 0001193125-26-091536.Report this figure127Total assets, Q1 FY2025, at 2025-03-31$127.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure102Total assets, Q2 FY2025, at 2025-06-30$102.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure190Total assets, Q3 FY2025, at 2025-09-30$190.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure174Total assets, FY2025, at 2025-12-31$173.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure156Total assets, Q1 FY2026, at 2026-03-31$156.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure141Total assets, Q2 FY2026, at 2026-06-30$141.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Current liabilities$m21.0Current liabilities, Q3 FY2023, at 2023-09-30$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060702.Report this figure17.5Current liabilities, FY2023, at 2023-12-31$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-24, accession 0000950170-25-025226.Report this figure11.3Current liabilities, Q1 FY2024, at 2024-03-31$11.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059519.Report this figure22.1Current liabilities, Q2 FY2024, at 2024-06-30$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093351.Report this figure16.8Current liabilities, Q3 FY2024, at 2024-09-30$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure16.7Current liabilities, FY2024, at 2024-12-31$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-04, accession 0001193125-26-091536.Report this figure20.4Current liabilities, Q1 FY2025, at 2025-03-31$20.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure16.4Current liabilities, Q2 FY2025, at 2025-06-30$16.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure12.6Current liabilities, Q3 FY2025, at 2025-09-30$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure12.6Current liabilities, FY2025, at 2025-12-31$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure9.0Current liabilities, Q1 FY2026, at 2026-03-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure9.0Current liabilities, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Total liabilities$m38.4Total liabilities, Q3 FY2023, at 2023-09-30$38.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-060702.Report this figure34.6Total liabilities, FY2023, at 2023-12-31$34.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-24, accession 0000950170-25-025226.Report this figure28.0Total liabilities, Q1 FY2024, at 2024-03-31$28.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059519.Report this figure38.5Total liabilities, Q2 FY2024, at 2024-06-30$38.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093351.Report this figure32.8Total liabilities, Q3 FY2024, at 2024-09-30$32.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure32.3Total liabilities, FY2024, at 2024-12-31$32.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-04, accession 0001193125-26-091536.Report this figure35.6Total liabilities, Q1 FY2025, at 2025-03-31$35.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure31.1Total liabilities, Q2 FY2025, at 2025-06-30$31.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure26.9Total liabilities, Q3 FY2025, at 2025-09-30$26.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure26.5Total liabilities, FY2025, at 2025-12-31$26.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure22.3Total liabilities, Q1 FY2026, at 2026-03-31$22.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure21.9Total liabilities, Q2 FY2026, at 2026-06-30$21.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure
Shareholders' equity$m126Shareholders' equity, Q3 FY2023, at 2023-09-30$125.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure108Shareholders' equity, FY2023, at 2023-12-31$108.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-04, accession 0001193125-26-091536.Report this figure179Shareholders' equity, Q1 FY2024, at 2024-03-31$179.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure155Shareholders' equity, Q2 FY2024, at 2024-06-30$155.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure137Shareholders' equity, Q3 FY2024, at 2024-09-30$137.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure119Shareholders' equity, FY2024, at 2024-12-31$118.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure91.8Shareholders' equity, Q1 FY2025, at 2025-03-31$91.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure71.2Shareholders' equity, Q2 FY2025, at 2025-06-30$71.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure163Shareholders' equity, Q3 FY2025, at 2025-09-30$163.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure147Shareholders' equity, FY2025, at 2025-12-31$147.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure134Shareholders' equity, Q1 FY2026, at 2026-03-31$134.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure120Shareholders' equity, Q2 FY2026, at 2026-06-30$119.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure

Cash flow

Operating cash flow−$15.8m, Q2 FY2026
Capital expenditure$30.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(16.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122821. Derived: 9-month figure less the 6-month figure.Report this figure(19.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-24, accession 0000950170-25-025226. Derived: 12-month figure less the 9-month figure.Report this figure(22.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$22.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure(16.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001193125-25-174979. Derived: 6-month figure less the 3-month figure.Report this figure(24.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276001. Derived: 9-month figure less the 6-month figure.Report this figure(19.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure(22.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$22.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(23.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$23.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336754. Derived: 6-month figure less the 3-month figure.Report this figure(19.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276001. Derived: 9-month figure less the 6-month figure.Report this figure(15.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure(18.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure(15.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336754. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$225.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122821. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$184.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-24, accession 0000950170-25-025226. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$53.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001193125-25-174979. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$185.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276001. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$228.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$125.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336754. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$97.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276001. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001193125-26-091536. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336754. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)69.20m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares23.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3023,562,395 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-060702.Report this figure23.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3123,761,915 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059519.Report this figure23.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3023,790,430 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093351.Report this figure23.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3023,790,430 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122821.Report this figure28.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3128,656,401 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066414.Report this figure32.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3032,469,187 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001193125-25-174979.Report this figure32.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3032,581,542 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure32.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3132,674,720 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure32.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3032,748,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure34.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3034,362,876 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276001.Report this figure69.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3169,091,100 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219375.Report this figure69.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3069,202,376 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure

Shares outstanding: 69.26mShares outstanding, period not labelled, at 2026-08-0269,259,517 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336754.Report this figure at Aug 2, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.